Skip to main content
. 2020 Sep 1;34:100625. doi: 10.1016/j.gore.2020.100625

Fig. 3.

Fig. 3

Computed tomography (CT) imaging demonstrates an interval decrease in the size of pulmonary metastatic nodules following treatment with 25 cycles of pembrolizumab (A, pre-treatment; B, pembrolizumab therapy).